NCT01728571View on ClinicalTrials.gov

LungVITamin D and OmegA-3 Trial (lungVITAL)

NAActive, not recruitingINTERVENTIONAL
Enrollment

25,871

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

November 10, 2018

Study Completion Date

February 28, 2025

Conditions
COPDAsthmaPulmonary FunctionPneumonia
Interventions
DIETARY_SUPPLEMENT

Vitamin D3

DIETARY_SUPPLEMENT

fish oil

DIETARY_SUPPLEMENT

Vitamin D3 placebo

DIETARY_SUPPLEMENT

Fish oil placebo

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Harvard School of Public Health (HSPH)

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT01728571 - LungVITamin D and OmegA-3 Trial (lungVITAL) | Biotech Hunter | Biotech Hunter